EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hospitalization and Emergency Department Costs in Patiromer and Sodium Zirconium Cyclosilicate Users

Nihar R Desai, Charuhas Thakar, Tejas Desai iD, Marco Soro, Jeffrey Budden, Nathan Kleinman iD

Kidney360 · 2026-07 · 7 (7) · 1516-1521

DOI: 10.34067/kid.0000001195 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney360, online erschienen am 01.04.2026. Verfasst von Nihar R Desai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Yale School of Medicine, New Haven, Connecticut. Hauptthemen laut MEDLINE: Hospitalization, Silicates, Heart Failure, Emergency Service, Hospital. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CSL Vifor US.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Key Points This study shows a statistically significant 15% potential heart failure hospitalization and edema event cost savings among patiromer users. Annual costs were $52,153 in the sodium zirconium cyclosilicate cohort and $44,245 in the patiromer cohort, an annual difference of $7908 per person. In addition to clinical benefits, these results highlight financial implications for health plans, value-based care organizations, and patients Background A previous study using US electronic health records directly compared the risk of heart failure–related or edema-related hospitalizations and edema-related emergency department (ED) visits for hyperkalemic patients using patiromer or sodium zirconium cyclosilicate. Incidence rates for all three clinical outcomes favored patiromer, but the previous study did not capture costs.

Methods

The current investigation combines the patiromer and sodium zirconium cyclosilicate cohort heart failure hospitalization and edema event rates from the previous study with mean event and prescription costs from 2019 to 2021 Optum Clinformatics data. The resulting heart failure–related and edema-related event and medication costs were then compared between patiromer and sodium zirconium cyclosilicate cohorts. We inflation-adjusted those to 2024 US dollars.

Results

For patiromer, costs for heart failure hospitalizations, edema hospitalizations, and edema ED visits were $30,269.05, $2520.13, and $31.67 per person-year, respectively. For sodium zirconium cyclosilicate, costs for heart failure hospitalizations, edema hospitalizations, and edema ED visits were $39,478.29, $4061.48, and $51.04, respectively. Medication costs per person-year were $11,423.68 and $8561.71 for patiromer and sodium zirconium cyclosilicate, respectively. The aggregated cost savings with patiromer was $7907.99 per person-year (95% confidence interval, $5453.58 to $10,362.40) for all heart failure hospitalization and edema hospitalization and ED events, adjusted for both inflation and medication costs.

Conclusions

Total event and medication costs were $44,245 in the patiromer cohort and $52,153 in the sodium zirconium cyclosilicate cohort. The $7908 difference represents a 15% (95% confidence interval, 10% to 20%) cost savings associated with patiromer from all events, including medication costs and adjusted for inflation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HospitalizationSilicatesHeart FailureEmergency Service, HospitalPolymersHyperkalemiaEdemaHumansEmergency Room VisitsFemaleAged

Stichwörter der Autor:innen

CKDheart failurehospitalizationhyperkalemiarenin-angiotensin systemsodium (Na+) transport

Substanzen

Silicatessodium zirconium cyclosilicatepatiromerPolymers

Autor:innen und Institutionen

  • Yale School of Medicine, New Haven, Connecticut.
  • Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, United Kingdom.
  • CSL Vifor US, King of Prussia, Pennsylvania.
  • CSL Vifor Glattbrugg, ZH, Switzerland.
  • Kleinman Analytic Solutions, LLC, Paso Robles, California.

ORCID-Profile: Tejas Desai, Nathan Kleinman

Förderung

  • CSL Vifor US

Zitieren

APA

Desai, N. R., Thakar, C., Desai, T., Soro, M., Budden, J., & Kleinman, N. (2026). Hospitalization and Emergency Department Costs in Patiromer and Sodium Zirconium Cyclosilicate Users. Kidney360, 7(7), 1516-1521. https://doi.org/10.34067/kid.0000001195

Vancouver

Desai NR, Thakar C, Desai T, Soro M, Budden J, Kleinman N. Hospitalization and Emergency Department Costs in Patiromer and Sodium Zirconium Cyclosilicate Users. Kidney360. 2026;7(7):1516-1521. doi:10.34067/kid.0000001195

BibTeX
@article{Desai2026,
  author = {Desai, Nihar R and Thakar, Charuhas and Desai, Tejas and Soro, Marco and Budden, Jeffrey and Kleinman, Nathan},
  title = {Hospitalization and Emergency Department Costs in Patiromer and Sodium Zirconium Cyclosilicate Users},
  journal = {Kidney360},
  year = {2026},
  volume = {7},
  number = {7},
  pages = {1516--1521},
  doi = {10.34067/kid.0000001195}
}
Kostenlos starten →